IgG4-related disease in pulmonary arterial hypertension on long-term epoprostenol treatment

Eur Respir J. 2014 May;43(5):1516-9. doi: 10.1183/09031936.00144013. Epub 2014 Jan 16.

Authors

Yuichiro Shirai¹, Yuichi Tamura, Hidekata Yasuoka, Toru Satoh, Masataka Kuwana

Affiliation

¹ Dept of Internal Medicine, Keio University School of Medicine, Tokyo.

PMID: 24435006
DOI: 10.1183/09031936.00144013

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Antihypertensive Agents / therapeutic use*
Disease Progression
Epoprostenol / therapeutic use*
Familial Primary Pulmonary Hypertension / complications*
Familial Primary Pulmonary Hypertension / drug therapy*
Female
Hemodynamics
Humans
Immunoglobulin G / chemistry*
Inflammation / complications*
Inflammation / drug therapy*
Middle Aged
T-Lymphocytes / immunology
Treatment Outcome
Young Adult

Substances

Antihypertensive Agents
Immunoglobulin G
Epoprostenol